ET
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 27 Sept 2025)
What this means for you
Registered since 21 May 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87840660
- Registration number
- 5758909
- Mark type
- Word mark
- Filed
- 19 Mar 2018
- Published for opposition
- 31 Jul 2018
- Registered
- 21 May 2019
- Attorney of record
- Otto O. Lee
Goods and services
- Class 042 — Scientific and technological services: Medical research; Medical and scientific research in the field of oncology and immunology; Medical and scientific research in the field of immunotherapy and antibodies; Medical research services in the field of cancer; Scientific research; Contract research services, namely, medical, pharmaceutical, and scientific research for others
Owner
- Eureka Therapeutics, Inc., Emeryville, CA, US
- Eureka Therapeutics, Inc., Emeryville, CA, US
- Eureka Therapeutics, Inc., Emeryville, CA, US
Prosecution history
- 27 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Sept 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 27 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 May 2025 — TEAS SECTION 8 & 15 RECEIVED
- 21 May 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Apr 2021 — CORRECTION UNDER SECTION 7 - PROCESSED
- 19 Apr 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Feb 2021 — TEAS SECTION 7 REQUEST RECEIVED
- 21 May 2019 — REGISTERED-PRINCIPAL REGISTER
- 18 Apr 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Apr 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Apr 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Mar 2019 — USE AMENDMENT FILED
- 09 Apr 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Mar 2019 — TEAS STATEMENT OF USE RECEIVED